(a) MLPA: Heterozygous deletion of CFHR1 (MIM# 34371) and CFHR3 (MIM#605336), hemolytic uremic syndrome, atypical, susceptibility to (MIM#: 235,400, AD AR), heterozygous. (b) NM_001710.5(CFB):c.1697A>C, p.E566A (MIM#138470), hemolytic uremic syndrome, atypical, susceptibility to, 4 (MIM#612924, AD), heterozygous. (c) NM_139025.3 (ADAMTS13):c.2915G>A, p.R972Q (MIM#604134), thrombotic thrombocytopenic purpura, hereditary (MIM#274150, AR), heterozygous. This evidence concerns the gene CFHR3 and hemolytic-uremic syndrome.